|
|
Article: Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors.(Medical condition overview)
- Article from:
- Business Wire
- Article date:
- January 17, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Findings Published in Stem Cells and Development Indicate GRNOPC1 Promotes Survival and Regeneration of Neurons Damaged During Spinal Cord Injury
MENLO PARK, Calif. -- Geron Corporation (Nasdaq: GERN) today reported that studies show GRNOPC1, the company's human embryonic stem cell (hESC)-based oligodendroglial progenitor therapeutic, produces multiple nerve growth factors, proteins that stimulate the survival and regeneration of neurons damaged during spinal cord injury.
Published in Stem Cells and Development (Vol. 15, Issue 6, 943-952), the studies conducted by Geron scientists describe a newly discovered neurotrophic effect that, in addition to the ...